Document is current
Any future updates will be listed below
-
Authors
Steens, Jurre A.
Zhu, Yifan
Taylor, David W. https://orcid.org/0000-0002-6198-1194
Bravo, Jack P. K.
Prinsen, Stijn H. P. https://orcid.org/0000-0001-6863-3160
Schoen, Cor D.
Keijser, Bart J. F.
Ossendrijver, Michel
Hofstra, L. Marije
Brouns, Stan J. J. https://orcid.org/0000-0002-9573-1724
Shinkai, Akeo https://orcid.org/0000-0002-9867-0832
van der Oost, John https://orcid.org/0000-0001-5024-1871
Staals, Raymond H. J. https://orcid.org/0000-0002-5741-9457
-
Funding
Funding for this research was provided by:
Suomalainen Lääkäriseura Duodecim
Welch Foundation (F-1938)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM138348)
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
Cancer Prevention and Research Institute of Texas (RR160088)
United States Department of Defense | United States Army | U.S. Army Research, Development and Engineering Command | Army Research Office (W911NF-19-1-0021)
Nederlands Instituut voor Onderzoek van de Gezondheidszorg (VI.C.182.027)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (714.015.001, 016.Veni.171.047)
- License Information
-
More Information
Article History
Received: 26 February 2021
Accepted: 30 July 2021
First Online: 19 August 2021
Competing interests
: The Authors declare the following competing interests. J.A.S., S.H.P.P. are founders and shareholders of Scope Biosciences. J.v.d.O., R.H.J.S. are shareholders and members of the scientific board of Scope Biosciences. J.A.S., J.v.d.O., R.H.J.S., S.H.P.P. are inventors on type III CRISPR-Cas related patents. Authors Y.Z., D.W.T., J.P.K.B., C.D.S., B.J.F.K., M.O., L.M.H., S.J.J.B. and A.S. declare no competing interests.
